AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Anti C. elegans cyclin E (CYE1, full-length recombinant protein prepared in bacteria), Line 17C8

Detailed Technology Description: Applications This mouse monoclonal antibody was generated againstfull-length recombinant cyclin E (CYE-1) protein and is specific for Caenorhabditis elegans CYE-1 full-lengthrecombinant protein (prepared in bacteria)and has been validated for usein WB, IF (1:100-300). Cyclin E is a member of the cyclin family of proteins, whichregulates the cell cycle through its activation of cyclin-dependent kinases.Specifically, cyclin E binds and activates the S phase Cdk2. The cyclin E–Cdk2complex promotes the G1 to S phase cell cycle transition. Overexpression ofcyclin E has been implicated in carcinomas among the gastrointestinal tract,including colon or stomach cancer as well as a marker for breast cancers.

*Abstract: ReagentDescription
Antigen: rec- C. elegans CYE-1
AccessionID: NM_001025857.2
MolecularWeight: 60.6 kDa
CloneName: 17C8
Reactivity: C.elegans / C. briggsae
Immunogen: Full-length recombinant CYE-1 protein
SpeciesImmunized: Mouse
PurificationMethod: Not purified; used as antibodysupernatant
TestedApplications: WB, IF.
MAbstorage: -80^oC
References

Brodigan, T.M.,Liu, J., Park, M., Kipreos, E.T., and Krause, M. 2003. Cyclin E expressionduring development in C. elegans. DevelopmentalBiology 254: 102-115.
Kim, Y., andKipreos, E.T. 2007. The C. elegans replication licensing factor CDT-1 istargeted for degradation by the CUL-4/DDB-1 complex. Molecular and Cellular Biology 27:1394-1406.
The, I.,Ruijtenberg, S., Bouchet, B. P., Cristobal, A., Prinsen, M. B., van Mourik, T.,Koreth, J., Xu, H., Heck, A. J., Akhmanova, A., Cuppen, E., Boxem, M., Munoz,J., & van den Heuvel, S. (2015). Rb and FZR1/Cdh1 determine CDK4/6-cyclin Drequirement in C. elegans and human cancer cells. Nat Commun, 6, 5906.
Fox, P. M.,Vought, V. E., Hanazawa, M., Lee, M. H., Maine, E. M., & Schedl, T. (2011).Cyclin E and CDK-2 regulate proliferative cell fate and cell cycle progressionin the C. elegans germline. Development, 138, 2223-34.

Country/Region: USA

For more information, please click Here